European Medicines Agency (EMA)

New antibiotic for hospital-acquired pneumonia now available in Europe

The antibiotic telavancin (Vibativ) has been made available in Europe for the treatment of adults who have contracted pneumonia in hospital, including ventilator associated pneumonia, caused by meticillin-resistant Staphylococcus aureus.…

Role for smartphones and social media in medicine safety

An app will be developed to make it easy for healthcare professionals and the public to report suspected adverse drug reactions.…

Ten-year study by Takeda calls into question pioglitazone’s link with bladder cancer

Use of the diabetes drug pioglitazone is not associated with an increased risk of bladder cancer, the drug’s manufacturer Takeda has claimed.…